FDA approves leucovorin to treat rare cerebral folate deficiency

The Food and Drug Administration has approved expanded use of leucovorin calcium tablets for treating cerebral folate deficiency, a rare disorder.

FDA approves Wellcovorin for ultra-rare disease. The Trump admin touted it as a treatment for autism

The Food and Drug Administration (FDA) on Tuesday granted expanded approval to Wellcovorin for the ultra-rare disease cerebral folate deficiency (CFD) in both children and adults, the same ...

FDA approves generic drug for a rare genetic condition, but not for autism

Dr. Marty Makary, the FDA’s commissioner, said in a statement that the “approval represents a significant milestone for ...
MPR

Leucovorin Tablets Approved for Cerebral Folate Transport Deficiency

Cerebral folate deficiency is a rare neurological disorder characterized by a decrease in CSF folate levels, leading to developmental regression, seizures, movement disorders, and other neurological ...
MiBolsilloColombia on MSN

FDA approves leucovorin for cerebral folate deficiency

The FDA has approved Wellcovorin (leucovorin) for cerebral folate deficiency (CFD-FOLR1), the first-ever treatment for the rare genetic neurological condition.

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

The move comes months after the Trump administration touted leucovorin as a potential therapy for a broader group of patients with autism symptoms.

FDA Approves Drug Trump Touted for Autism to Treat Other Neurological Disorder

The Food and Drug Administration approved leucovorin to treat a neurological disorder with some symptoms similar to autism.
MedPage Today

FDA Reverses Stance on Leucovorin for Autism

Leucovorin is now indicated for adult and pediatric patients with a confirmed variant in the folate receptor 1 gene, the agency said. This disorder affects fewer than one in 1 million people, with ...

FDA finds little evidence that a generic drug can help people with autism

It's a major step back from statements made at a White House news conference in September, when President Donald Trump and FDA commissioner Marty Makary announced the drug was under review to benefit ...

FDA expands use of generic drug to treat autism-linked genetic disorder

The U.S. Food and Drug Administration (FDA) on Tuesday approved the expanded use of Wellcovorin (leucovorin calcium) tablets. The approval covers cerebral folate deficiency in adult and pediatric ...

US FDA approves leucovorin for ultra- rare genetic disorder causing autism-like symptoms

By Ahmed Aboulenein and Julie Steenhuysen WASHINGTON, March 10 (Reuters) - The U.S. FDA on Tuesday approved leucovorin, a decades-old generic drug, for use against an ultra-rare disorder called ...

FDA approves leucovorin for rare disorder, but not for autism after Trump's claims of drug ...

In September, Trump and the FDA commissioner announced the drug was under review to benefit patients with autism. The FDA didn't find evidence of that.